midazolam has been researched along with kainic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Layton, ME; Pazdernik, TL; Samson, FE | 1 |
| Boehrer, A; Depaulis, A; Heinrich, C; Kurokawa, K; Matsuda, M; Mitsuya, K; Suzuki, F | 1 |
| Danhof, M; Gunput, RA; Liefaard, LC; Voskuyl, RA | 1 |
| Mitsuya, K; Nitta, N; Suzuki, F | 1 |
| Dhir, A; Rogawski, MA; Zolkowska, D | 1 |
| Depaulis, A; Laharie, AM; Nitta, N; Nozaki, K; Shima, A; Suzuki, F | 1 |
| Diviney, M; Henshall, DC; Reynolds, JP | 1 |
7 other study(ies) available for midazolam and kainic acid
| Article | Year |
|---|---|
Kainic acid causes redox changes in cerebral cortex extracellular fluid: NMDA receptor activity increases ascorbic acid whereas seizure activity increases uric acid.
Topics: Animals; Antioxidants; Ascorbic Acid; Cerebral Cortex; Excitatory Amino Acid Agonists; Extracellular Space; Kainic Acid; Male; Microdialysis; Midazolam; Oxidation-Reduction; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Uric Acid | 1998 |
Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy.
Topics: Animals; Benzodiazepines; Cell Count; Dentate Gyrus; Disease Models, Animal; Dizocilpine Maleate; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; GABA Modulators; Hippocampus; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Midazolam; Mossy Fibers, Hippocampal; Neurons; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2005 |
Decreased Efficacy of GABAA-receptor modulation by midazolam in the kainate model of temporal lobe epilepsy.
Topics: Animals; Autoradiography; Beta Rhythm; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Flumazenil; Injections, Intraperitoneal; Kainic Acid; Midazolam; Rats; Receptors, GABA-A; Status Epilepticus; Treatment Outcome; Tritium | 2007 |
Persistent zinc depletion in the mossy fiber terminals in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Topics: Animals; Carrier Proteins; Cation Transport Proteins; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Glutamic Acid; Hippocampus; Hypnotics and Sedatives; Kainic Acid; Male; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Microdialysis; Midazolam; Mossy Fibers, Hippocampal; Synapsins; Time Factors; Vesicular Glutamate Transport Protein 1; Zinc | 2009 |
Seizure protection by intrapulmonary delivery of midazolam in mice.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Routes; Kainic Acid; Male; Mice; Midazolam; Pentylenetetrazole; Picrotoxin; Seizures | 2013 |
Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy.
Topics: Animals; Astrocytes; Brain-Derived Neurotrophic Factor; Central Nervous System Agents; Disease Models, Animal; Epilepsy, Temporal Lobe; Gliosis; Hippocampus; Kainic Acid; Male; Mice, Inbred C57BL; Midazolam; Neural Inhibition; Neurons; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2015 |
Comparison of short-term effects of midazolam and lorazepam in the intra-amygdala kainic acid model of status epilepticus in mice.
Topics: Amygdala; Animals; Anticonvulsants; Benzodiazepines; Disease Models, Animal; Hippocampus; Kainic Acid; Lorazepam; Male; Mice; Mice, Inbred C57BL; Midazolam; Status Epilepticus; Treatment Outcome | 2015 |